妊娠期铁状态与妊娠期糖尿病风险的纵向研究:来自前瞻性多种族队列的发现
在2009-2013年前瞻性多种族妊娠队列中嵌套病例对照研究,107例妊娠期糖尿病(GDM)与214例对照比较孕早中期铁生物标志物。孕15-26周铁蛋白最高较低四分位GDM风险aOR 3.95(95%CI 1.38, 11.30),可溶性转铁蛋白受体:铁蛋白比值最高较低四分位aOR 0.15(95%CI 0.05, 0.48)。作者认为铁储备升高可能自孕早期即参与GDM发生,对铁充足孕妇常规补铁推荐提出潜在担忧。
要点
- 孕15-26周铁蛋白最高vs最低四分位GDM风险aOR 3.95(95%CI 1.38, 11.30)
- 孕10-14周铁蛋白最高vs最低四分位GDM风险aOR 2.43(95%CI 1.12, 5.28)
- sTfR:铁蛋白比值最高vs最低四分位孕15-26周GDM风险aOR 0.15(95%CI 0.05, 0.48)
核心结论
- 作者认为铁储备升高可能自孕早期即参与GDM发生,对铁充足孕妇常规补铁推荐提出潜在担忧。
研究设计与样本
- 在2009-2013年前瞻性多种族妊娠队列(Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies-Singleton Cohort)内开展病例对照研究,107例GDM与214例对照按年龄、种族/民族和采血孕周匹配。
主要发现
- 孕15-26周GDM组铁调素中位数6.4 ng/ml vs 对照组5.5 ng/ml,GDM组较对照组高16%(p=0.02)。
- 铁蛋白与GDM风险正相关:孕10-14周最高vs最低四分位aOR 2.43(95%CI 1.12, 5.28);孕15-26周最高vs最低四分位aOR 3.95(95%CI 1.38, 11.30)。
- sTfR:铁蛋白比值与GDM风险负相关:孕10-14周最高vs最低四分位aOR 0.33(95%CI 0.14, 0.80);孕15-26周最高vs最低四分位aOR 0.15(95%CI 0.05, 0.48)。
- 铁调素最高vs最低四分位GDM风险aOR 2.61(95%CI 1.07, 6.36)。
临床怎么用
- 作者认为铁储备升高可能自孕早期即参与GDM发生,并对铁充足孕妇常规补铁推荐提出潜在担忧。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this study was to prospectively and longitudinally investigate maternal iron status during early to mid-pregnancy, and subsequent risk of gestational diabetes mellitus (GDM), using a comprehensive panel of conventional and novel iron biomarkers. METHODS: A case-control study of 107 women with GDM and 214 controls (matched on age, race/ethnicity and gestational week during blood collection) was conducted within the the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies-Singleton Cohort (2009-2013), a prospective and multiracial pregnancy cohort. Plasma hepcidin, ferritin and soluble transferrin receptor (sTfR) were measured and sTfR:ferritin ratio was derived, twice before GDM diagnosis (gestational weeks 10-14 and 15-26) and at weeks 23-31 and 33-39. GDM diagnosis was ascertained from medical records. Adjusted ORs (aORs) for GDM were estimated using conditional logistic regression analysis, adjusting for demographics, prepregnancy BMI and other major risk factors. RESULTS: Hepcidin concentrations during weeks 15-26 were 16% higher among women with GDM vs controls (median 6.4 vs 5.5 ng/ml; p = 0.02 ), and were positively associated with GDM risk; the aOR (95% CI) for highest vs lowest quartile was 2.61 (1.07, 6.36). Ferritin levels were also positively associated with GDM risk; the aOR (95% CI) for highest vs lowest quartile was 2.43 (1.12, 5.28) at weeks 10-14 and 3.95 (1.38, 11.30) at weeks 15-26. The sTfR:ferritin ratio was inversely related to GDM risk; the aOR (95% CI) for highest vs lowest quartile was 0.33 (0.14, 0.80) at weeks 10-14 and 0.15 (0.05, 0.48) at weeks 15-26. CONCLUSIONS/INTERPRETATION: Our findings suggest that elevated iron stores may be involved in the development of GDM from as early as the first trimester. This raises potential concerns for the recommendation of routine iron supplementation among iron-replete pregnant women.
引用
- Rawal S, Hinkle SN, Bao W, et al. A longitudinal study of iron status during pregnancy and the risk of gestational diabetes: findings from a prospective, multiracial cohort. Diabetologia. 2016. PMID: 27830277. doi:10.1007/s00125-016-4149-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。